Novartis suspends tegaserod sales at FDA's request.
Thompson
Cheryl A
CA
D017277:Drug Approval; D004345:Drug Industry / Q000331:legislation & jurisprudence*; D006801:Humans; D007211:Indoles / Q000009:adverse effects* / Q000627:therapeutic use; D043183:Irritable Bowel Syndrome / Q000188:drug therapy; D018570:Risk Assessment; D058828:Serotonin 5-HT4 Receptor Agonists; D014481:United States; D014486:United States Food and Drug Administration
D007211:Indoles; D058828:Serotonin 5-HT4 Receptor Agonists; C105050:tegaserod